The phosphatidylinositol 3-kinase-δ inhibitor CAL-101 demonstrates promising pre-clinical activity in chronic lymphocytic leukemia by antagonizing intrinsic and extrinsic cellular survival signals

Sarah E. M. Herman, Amber L. Gordon, Amy J. Wagner, Nyla A. Heerema, Weiqiang Zhao, Joseph M. Flynn, Jeffrey Jones, Leslie Andritsos, Kamal D. Puri, Brian J. Lannutti, Neill A. Giese, Xiaoli Zhang, Lai Wei, John C. Byrd and Amy J. Johnson

Article Information


Print ISSN 
Online ISSN 
  • Submitted February 25, 2010
  • Accepted May 24, 2010
  • Published online June 3, 2010.

Article Versions

  • Sarah E. M. Herman
  • Amber L. Gordon
  • Amy J. Wagner
  • Nyla A. Heerema
  • Weiqiang Zhao
  • Joseph M. Flynn
  • Jeffrey Jones
  • Leslie Andritsos
  • Kamal D. Puri
  • Brian J. Lannutti
  • Neill A. Giese
  • Xiaoli Zhang
  • Lai Wei
  • John C. Byrd
  • Amy J. Johnson Statistics

The Altmetric score is a weighted count of online attention designed to reflect the volume and reach of online engagement surrounding an individual research output